Literature DB >> 27402674

Novel role for p56/Lck in regulation of endothelial cell survival and angiogenesis.

Venkaiah Betapudi1, Meenal Shukla2, Ravi Alluri2, Sergei Merkulov2, Keith R McCrae3.   

Abstract

Previous studies have demonstrated that cleaved high-molecular-weight kininogen (HKa) induces endothelial apoptosis and inhibits angiogenesis and have suggested that this occurs through inhibition of Src family kinases. This study assessed the role of tyrosine-protein kinase Lck (p56/Lck) in this pathway. We analyzed early events leading to apoptosis of human endothelial cells exposed to HKa. The role of p56/Lck was investigated using short interfering (si) RNA knockdown and lentivirus expression in assays of endothelial tube formation, sprouting of neovessels from murine aorta, and angiogenesis in Matrigel plugs. HKa stimulated expression and phosphorylation of p56/Lck. siRNA knockdown of p56/Lck promoted endothelial proliferation and blocked HKa-induced apoptosis and activation of p53, Bax, and Bak. Lentivirus expression of p56/Lck in endothelial cells induced apoptosis and blocked tube formation. Expression of p56/Lck in murine aortic rings blocked sprouting angiogenesis. Lentivirus expressing p56/Lck blocked angiogenesis in Matrigel plugs, while p56/Lck short hairpin RNA inhibited the antiangiogenic effect of HKa. Scrambled siRNAs and empty lentiviral vectors were used in all experiments. Apoptosis of proliferating endothelial cells and inhibition of angiogenesis by HKa requires p56/Lck. This suggests a novel role for p56/Lck in regulation of endothelial cell survival and angiogenesis.-Betapudi, V., Shukla, M., Alluri, R., Merkulov, S., McCrae, K. R. Novel role for p56/Lck in regulation of endothelial cell survival and angiogenesis. © FASEB.

Entities:  

Keywords:  apoptosis; kininogen; p53; tyrosine protein kinase Lck

Mesh:

Substances:

Year:  2016        PMID: 27402674      PMCID: PMC5024698          DOI: 10.1096/fj.201500040

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  63 in total

1.  Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis.

Authors:  R W Colman; B A Jameson; Y Lin; D Johnson; S A Mousa
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

2.  Cooperative phosphorylation at multiple sites is required to activate p53 in response to UV radiation.

Authors:  M Kapoor; R Hamm; W Yan; Y Taya; G Lozano
Journal:  Oncogene       Date:  2000-01-20       Impact factor: 9.867

Review 3.  SRC: a century of science brought to the clinic.

Authors:  Alexey Aleshin; Richard S Finn
Journal:  Neoplasia       Date:  2010-08       Impact factor: 5.715

Review 4.  Phosphoprotein associated with glycosphingolipid-enriched microdomains/Csk-binding protein: a protein that matters.

Authors:  Alexandr Svec
Journal:  Pathol Res Pract       Date:  2008-08-29       Impact factor: 3.250

5.  A mutation in the human Uncoordinated 119 gene impairs TCR signaling and is associated with CD4 lymphopenia.

Authors:  Magdalena M Gorska; Rafeul Alam
Journal:  Blood       Date:  2011-12-19       Impact factor: 22.113

6.  The inhibition of tube formation in a collagen-fibrinogen, three-dimensional gel by cleaved kininogen (HKa) and HK domain 5 (D5) is dependent on Src family kinases.

Authors:  Yuchuan Liu; Irma M Sainz; Yi Wu; Robin Pixley; Ricardo G Espinola; Sarmina Hassan; Mohammad M Khan; Robert W Colman
Journal:  Exp Cell Res       Date:  2007-10-18       Impact factor: 3.905

7.  Urokinase-type plasminogen activator receptor is involved in mediating the apoptotic effect of cleaved high molecular weight kininogen in human endothelial cells.

Authors:  Dian J Cao; Yan-Lin Guo; Robert W Colman
Journal:  Circ Res       Date:  2004-03-25       Impact factor: 17.367

8.  Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells.

Authors:  A P Adamis; D T Shima; K T Yeo; T K Yeo; L F Brown; B Berse; P A D'Amore; J Folkman
Journal:  Biochem Biophys Res Commun       Date:  1993-06-15       Impact factor: 3.575

Review 9.  Regulation of angiogenesis and vascular permeability by Src family kinases: opportunities for therapeutic treatment of solid tumors.

Authors:  Serk In Park; Ami N Shah; Jing Zhang; Gary E Gallick
Journal:  Expert Opin Ther Targets       Date:  2007-09       Impact factor: 6.902

10.  Use of the mouse aortic ring assay to study angiogenesis.

Authors:  Marianne Baker; Stephen D Robinson; Tanguy Lechertier; Paul R Barber; Bernardo Tavora; Gabriela D'Amico; Dylan T Jones; Boris Vojnovic; Kairbaan Hodivala-Dilke
Journal:  Nat Protoc       Date:  2011-12-22       Impact factor: 13.491

View more
  6 in total

1.  A novel detection method of cleaved plasma high-molecular-weight kininogen reveals its correlation with Alzheimer's pathology and cognitive impairment.

Authors:  Hitomi Yamamoto-Imoto; Daria Zamolodchikov; Zu-Lin Chen; S Lloyd Bourne; Syeda Rizvi; Pradeep Singh; Erin H Norris; Frances Weis-Garcia; Sidney Strickland
Journal:  Alzheimers Dement (Amst)       Date:  2018-08-04

2.  Water-soluble variant of human Lynx1 induces cell cycle arrest and apoptosis in lung cancer cells via modulation of α7 nicotinic acetylcholine receptors.

Authors:  Maxim Bychkov; Zakhar Shenkarev; Mikhail Shulepko; Olga Shlepova; Mikhail Kirpichnikov; Ekaterina Lyukmanova
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

Review 3.  Gene Therapy Leaves a Vicious Cycle.

Authors:  Reena Goswami; Gayatri Subramanian; Liliya Silayeva; Isabelle Newkirk; Deborah Doctor; Karan Chawla; Saurabh Chattopadhyay; Dhyan Chandra; Nageswararao Chilukuri; Venkaiah Betapudi
Journal:  Front Oncol       Date:  2019-04-24       Impact factor: 6.244

4.  FGA Controls VEGFA Secretion to Promote Angiogenesis by Activating the VEGFR2-FAK Signalling Pathway.

Authors:  Hui Li; E Cai; Hongyan Cheng; Xue Ye; Ruiqiong Ma; Honglan Zhu; Xiaohong Chang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-13       Impact factor: 6.055

5.  FHIT, a Novel Modifier Gene in Pulmonary Arterial Hypertension.

Authors:  Svenja Dannewitz Prosseda; Xuefei Tian; Kazuya Kuramoto; Mario Boehm; Deepti Sudheendra; Kazuya Miyagawa; Fan Zhang; David Solow-Cordero; Joshua C Saldivar; Eric D Austin; James E Loyd; Lisa Wheeler; Adam Andruska; Michele Donato; Lingli Wang; Kay Huebner; Ross J Metzger; Purvesh Khatri; Edda Spiekerkoetter
Journal:  Am J Respir Crit Care Med       Date:  2019-01-01       Impact factor: 30.528

Review 6.  Cell Receptor and Cofactor Interactions of the Contact Activation System and Factor XI.

Authors:  Monika Pathak; Bubacarr Gibril Kaira; Alexandre Slater; Jonas Emsley
Journal:  Front Med (Lausanne)       Date:  2018-03-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.